Shenzhen stock exchange-listed Sino Biological has leased land to build a bioprocessing center and CRO in Levit Green, Houston. The new facility – which will be at a site leased from the real estate investment, development, and property manager Hines – will focus on product manufacture and the provision of contract research services. The aim is to provide drug industry sponsors and academic researchers working in the region with access to “bioreagents and CRO services” says Rob Burgess, Sino Biological’s chief business…
Friday, December 2, 2022 Daily Archives
Lonza adds AbTis conjugation tech to its ADC toolbox
CDMO Lonza has bolsted its antibody-drug conjugate (ADC) technology offering through the transfer of Korean biotech AbTis’ AbClick bioconjugation platform. Swiss contract development and manufacturing organization (CDMO) Lonza is a self-proclaimed “pioneer in bioconjugation,” having been involved in the space since 2006 and being the names third-party for the majority of the approved ADC products, as well as a wide range of other protein conjugates. The firm has built out its network over the past few years to support greater…
Pfizer gives green light to $1.26bn Ireland expansion
Pfizer has announced its largest Irish investment weeks after rumors emerged of a €1 billion+ expansion at its Grange Castle, Dublin biomanufacturing site. In October, the Irish press revealed Pfizer was set to invest €1 billion into the 90-acre manufacturing site in Clondalkin, Dublin. At the time, the Big Pharma firm refused to comment when contacted by this publication. But six weeks on, and the cat is out of the single-use bag, with Pfizer formalizing the €1.2 ($1.26) billion investment…